PROHANCE

This brand name is authorized in Austria, Brazil, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Japan, Lithuania, Poland, Romania, United Kingdom

Active ingredients

The drug PROHANCE contains one active pharmaceutical ingredient (API):

1 Gadoteridol
UNII 0199MV609F - GADOTERIDOL

Gadoteridol is a non-ionic paramagnetic contrast medium for Magnetic Resonance Imaging. Gadoteridol is for diagnostic use only.

Read about Gadoteridol

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
PROHANCE Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
V08CA04 Gadoteridol V Various → V08 Contrast media → V08C Magnetic resonance imaging contrast media → V08CA Paramagnetic contrast media
Discover more medicines within V08CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 540700201158419, 540700202154417, 540700203150415
Country: CA Health Products and Food Branch Identifier(s): 02229056
Country: EE Ravimiamet Identifier(s): 1778632, 1778643, 1778654, 1778665, 1778687, 1778698, 1778700
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 60377, 64474
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 539411, 539429, 539437, 539445
Country: FR Base de données publique des médicaments Identifier(s): 61258225, 69155907
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 399427, 399429, 399431, 399433, 399435
Country: JP 医薬品医療機器総合機構 Identifier(s): 7290407A1031, 7290407A2038, 7290407A3034, 7290407A4030, 7290407G1034, 7290407G2030
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1087973, 1087974, 1087975, 1087976, 1087977, 1087978, 1087979, 1087980, 1087981, 1087982, 1087983, 1087984, 1087985, 1091482, 1091483
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100097278
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W66183001, W66183002, W66183003, W66183004, W66183005, W66183006, W66183007, W66183008, W66184001, W66184002, W66184003, W66184004, W66184005, W66184006, W66184007, W66184008, W66184009
Country: US FDA, National Drug Code Identifier(s): 0270-1111

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.